Young oncologists in the coronavirus crisis: a learning opportunity
Despite some share the concern of having their career plans delayed or disrupted by the pandemic, the new challenges emerged in these unprecedented times represent a unique opportunity to grow-up as oncology professionals and get ready to a new scenario where team working, humanisation of care and virtual education will be more crucial than ever.
Telemedicine: the good and bad of living a hype
Present and Future of Cancer Immunotherapy
The current evidence suggests that a large proportion of patients not responding to PD-1/PD-L1-targeted agents do not have PD-L1-expressing tumours
Recognising Excellence in Oncology: ESMO Awards 2020
Lectures from this year’s ESMO awards recipients kick off the week leading up to the Education weekend of the ESMO Virtual Congress 2020
The Future of Genetics-led Cancer Therapeutics
A key advance in the fight against cancer is the availability of multiple treatment modalities developed to target different aspects of tumourigenesis and maintenance of cancer
The Promise of Combining Adoptive Cell Therapy With Checkpoint Inhibitors
At ESMO Virtual Congress 2020, the first report of clinical responses in multiple solid tumour subtypes increases knowledge on safety of tumour-infiltrating lymphocyte-based adoptive cell therapy combined with immunotherapy.